Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Doi

Showing results (61-70 of 247) with videos related to

Pageof 25
Sort By:
Investigational New Drugs|January 10, 2019
A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumorsToshihiko Doi, Takeshi Aramaki, Hirofumi Yasui, et al.
Journal of Surgical Oncology|April 22, 2016
Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgeryKen Hatogai, Satoshi Fujii, Takashi Kojima, et al.
Journal of Gastroenterology|May 14, 2003
Granular cell tumor occurring in the sigmoid colon treated by endoscopic mucosal resection using a transparent cap (EMR-C)Shinji Endo, Shoji Hirasaki, Toshihiko Doi, et al.
Journal for Immunotherapy of Cancer|October 14, 2018
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8<sup>+</sup> T cells in the tumor microenvironmentYasuko Tada, Yosuke Togashi, Daisuke Kotani, et al.
Gastrointestinal Endoscopy|November 27, 2015
Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinomaKen Hatogai, Tomonori Yano, Takashi Kojima, et al.
Journal of Gastroenterology|July 27, 2007
Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapyAyumu Hosokawa, Toshiro Sugiyama, Atsushi Ohtsu, et al.
Investigational New Drugs|November 27, 2012
A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Kensei Yamaguchi, et al.
International Journal of Clinical Oncology|May 9, 2008
Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancerNozomu Fuse, Toshihiko Doi, Atsushi Ohtsu, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2017
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysisToshihiko Doi, Tetsuya Hamaguchi, Kohei Shitara, et al.
Cancer|April 2, 2011
Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumorAkira Sawaki, Toshirou Nishida, Toshihiko Doi, et al.
Pageof 25

Showing results (61-70 of 247) with videos related to

Sort By:
Pageof 25
Investigational New Drugs|January 10, 2019
A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumorsToshihiko Doi, Takeshi Aramaki, Hirofumi Yasui, et al.
Journal of Surgical Oncology|April 22, 2016
Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgeryKen Hatogai, Satoshi Fujii, Takashi Kojima, et al.
Journal of Gastroenterology|May 14, 2003
Granular cell tumor occurring in the sigmoid colon treated by endoscopic mucosal resection using a transparent cap (EMR-C)Shinji Endo, Shoji Hirasaki, Toshihiko Doi, et al.
Journal for Immunotherapy of Cancer|October 14, 2018
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8<sup>+</sup> T cells in the tumor microenvironmentYasuko Tada, Yosuke Togashi, Daisuke Kotani, et al.
Gastrointestinal Endoscopy|November 27, 2015
Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinomaKen Hatogai, Tomonori Yano, Takashi Kojima, et al.
Journal of Gastroenterology|July 27, 2007
Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapyAyumu Hosokawa, Toshiro Sugiyama, Atsushi Ohtsu, et al.
Investigational New Drugs|November 27, 2012
A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Kensei Yamaguchi, et al.
International Journal of Clinical Oncology|May 9, 2008
Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancerNozomu Fuse, Toshihiko Doi, Atsushi Ohtsu, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2017
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysisToshihiko Doi, Tetsuya Hamaguchi, Kohei Shitara, et al.
Cancer|April 2, 2011
Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumorAkira Sawaki, Toshirou Nishida, Toshihiko Doi, et al.
Pageof 25